KMT2A-rearranged acute lymphoblastic leukemia (ALL) in infants is an aggressive disease with 3-year event-free survival below 40%. Most relapses occur during treatment, with two thirds occurring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results